The Honorary Membership is offered to a person who has made an unusual and outstanding contribution to the art and science of Fixed Prosthodontics. The AAFP has rarely offered this honor. During the Academy’s 67-year history, only eight individuals have been accorded Honorary Membership.
The membership was granted by Dr. Ronald Woody at the Friday luncheon during the Chicago Mid-Winter annual AAFP scientific meeting, attended by over 700 guests.
Dentsply Sirona Lab has been leading the promotion of ceramic framework materials since the turn of the millennium. In the zirconia arena, both the highly translucent Cercon ht and the extra translucent Cercon xt are now available alongside the pure white Cercon base. Cercon ht enables the laboratory to offer not only traditional veneered restorations, but also monolithic or partially veneered versions. Cercon xt, with its increased translucency, makes it even more appealing to use zirconia, even in the anterior tooth region without any veneering or only in a cut-back procedure.
Zirconia: monolithic and esthetic thanks to interior color gradient
A more rapid and color-stable treatment in the anterior tooth area can now be performed when using the new extra translucent Cercon xt ML multilayer blanks. These are a zirconia version with interior color gradient. Thus, even a monolithic treatment results in near-natural esthetics and only requires customization by adding a few colored accents—or the treatment can be completed without emphasizing any features. Needless to say, the exact treatment procedure is based on the individual patient, and the performance level "Esthetics unlimited" can typically be achieved by full veneering only.
With both the Cercon ht and the Cercon xt as well as the new Cercon xt ML, True Color Technology ensures enhanced shade stability. The blanks are available in all classic VITA1 shades.
Zirconia-reinforced lithium silicate: also for extra strong bridges
What if a more translucent solution is desired? Well, in that case, the laboratory uses ZLS Celtra Press. It is characterized by a stability that cannot be matched by any other comparable materials (three-point flexural strength: 567 MPa, biaxial strength: 678 MPa after power-fire heating). For the lab, this means: In addition to the restoration of individual teeth, three-unit bridges in the anterior tooth region (anterior to the second premolars as the terminal support) can be offered.
Celtra Press offers such a high degree of opalescence, translucency, and fluorescence that minimal highlighting can often lead to highly esthetic restorations. ZLS is available in the classic shades of BL2, A1, A2, and A3, as well as B1, C1, and D2, and now is expanded to B3, C3, and D3, each in two translucencies (LT, MT). Furthermore, the material will now be available to the laboratory in the colors MO1, MO2, and BL1 for specific use in discolored stumps. Thus, it is even easier for the dental technician to accurately reproduce the shade.
A major benefit for the holistic materials concept is the uniform esthetics option: both Cercon and Celtra Press can be veneered with the veneering ceramic Celtra Ceram. This provides a great basis for perfect harmony between a zirconia bridge in the posterior tooth region and crowns made of extra strong glass ceramics in the anterior tooth region.
The procedures differ: Cercon zirconia is manufactured using the CAD/CAM procedure involving production units (e.g., inLab MC X5) and sintered in a sintering furnace (e.g., inFire HTC speed or inLab Prosinter). The conventional press method is available for Celtra Press. Those who wish to avoid wax knife modeling can alternatively first convert their CAD design into a millable wax model (e.g., Wax Blank by Dentsply Sirona Lab) and then use conventional methods for further processing. This combined ‘analog/digital’ procedure is often referred to as "wax CAD." An entirely digital CAD/CAM workflow can be realized by using the monolithic ZLS Celtra Duo (e.g., inLab MC XL), with an ultimate durability (biaxial flexural strength) of 413 MPa after milling and polishing and 560 MPa after an optional glaze firing step, respectively.
Ever more positive surprises from the materials pipeline
"We have been able to pleasantly surprise customers with our innovative materials for digital or combined A/D processing," Julie Mroziak, Vice President Lab with Dentsply Sirona explains excitedly. "Who would have thought a few years ago that non-veneered anterior tooth restorations made of zirconia and anterior tooth bridges made of zirconia-reinforced lithium silicate could be obvious elements of a dental laboratory's portfolio? A good balance of durability and photo-optical properties carried out by our engineers and their close collaboration with dental technicians at various labs have formed the basis for this milestone. Nowadays, they can streamline their offering for any particular case in the treatment of a patient entirely based on the indication and the specific requirements in terms of esthetics, as well as the preferred type of fabrication."
1VITA is a registered trademark of Vita Zahnfabrik H. Rauter GmbH & Co. KG, Bad Säckingen.
Due to the different approval and registration times, not all technologies and products are immediately available in all countries.
One of the first organizations Tokuyama Empowers is partnering with is the American Academy of Cosmetic Dentistry Charitable Foundation’s (AACDCF) Give Back a Smile program. Give Back a Smile provides free dental care to adult women and men who have suffered dental injuries from domestic and sexual violence. By helping to restore their smiles, the program is healing some of the most devastating effects of the violence these victims endured and is supporting them on their road to recovery. Tokuyama Dental America has donated over $86,000 worth of products to Give Back a Smile, including Estelite Omega, a polychromatic esthetic composite system designed for anterior restorations with natural-looking results.
Corporate Social Responsibility has always been a core value of Tokuyama Corporation, the parent company of Tokuyama Dental. From its beginnings more than 100 years ago, the company’s mission has been to improve people’s lives and well-being. With Tokuyama Empowers, Tokuyama Dental America stays true to this heritage. “We believe dental health is crucial for personal well-being, and that everyone should have access to dental care. We are proud to partner with organizations dedicated to serving those in need, provide high-quality products for treatments, and give back to the community.” says Masa Ogata, CEO of Tokuyama Dental America.
For more information, please visit www.tokuyama-us.com, or call +1 (877) 378-3548
Tokuyama Dental America is a leading manufacturer of dental products, such as restoratives, adhesives, and denture reline material. As part of Tokuyama Corporation, the company looks back on more than 100 years of innovation and dedication to improving people’s lives and well-being through advances in science and chemistry. Tokuyama Dental’s products include innovations such as OMNICHROMA, the world’s only universal composite that matches every tooth shade with one shade of composite, Tokuyama Universal Bond, the first truly self-cured universal adhesive, and Rebase II, the market leader for hard denture reline materials. Tokuyama Dental America is dedicated to Innovating Tomorrow’s Dentistry, Today™.
Custom Milling Center (CMC) has announced that it will be welcoming Shaun McCourt as its Senior Production Manager. Shaun has more than 20 years of production and laboratory experience. Before joining CMC, he was the Production Manager at Digital Age Dental Laboratory in Binh Duong, Vietnam. Prior to Digital Age Dental Laboratory, he was General Manager at Reliable Arts Dental Lab/Laboratorio Dental Singergia in Costa Rica. During his time in Costa Rica, he was also the Clinical and Technical Director of Costa Rica Dental Team, a Tourism Dental Clinic.
Shaun brings a wealth of industry knowledge to CMC and will be responsible for all areas of production. He will be focusing on developing new processes to maximize efficiencies, as well as improving the customer experience and quality of all outgoing cases.
Formlabs is bringing some big news to IDS 2019 – in the form of personnel and materials.
Steffen Boehm will join the company as General Manager of Dental. Previously, Boehm served as Nobel Biocare’s Vice President, Digital Dentistry. The company will also reveal a broadened spectrum of Digital Denture shade options, now offering two color base options and a range of four tooth shades. Finally, Formlabs will release improvements to its Dental Model materials, which are used to create models and clear aligners. Now it can be printed at 140-micron settings, enabling one arch to be printed in under 45 minutes and 7 arches in under 4 hours.
Since the last IDS, Formlabs has made some significant progress in the dental and orthodontic industries, adding four new dental materials to its dental offering:
• Dental Model
• Dental LT Clear
• Digital Dentures
• Castable Wax
To date, Formlabs has a robust offering of six dental materials that are available to be used interchangeably on the Form 2 SLA 3D printer.
Since launching in the dental industry in 2016, Form 2 users have completed more than 175,000 surgeries with Dental SG, made more than 35,000 splints, and 3D printed more than 1.75 million dental parts.
PALM BEACH GARDENS, Fla. – March 12, 2019 – Zimmer Biomet today announced that four leading clinicians will present new data that reinforces the value of Trabecular Metal™ Dental Implants to improve outcomes in rapid recovery and risk management cases. The clinicians will also present cases demonstrating the BioBoost Effect™, a multiplication of naturally occurring growth factors that deliver faster healing and earlier bone formation than traditional implants. Zimmer Biomet's Trabecular Metal material is a unique, highly porous biomaterial made from elemental tantalum with a high degree of structural, functional and physiological properties similar to that of human cancellous bone. The presentations will take place during the Corporate Forum track at the Academy of Osseointegration (AO) Annual Meeting on March 14 in Washington, D.C.
“Unlike conventional implants, the Trabecular Metal implant offers three-dimensional bone growth promoting early implant stability, and therefore may offer beneficial conditions for accelerated healing in implant therapy,” said Hai Bo Wen, Clinical Research Director, Zimmer Biomet Dental. “A growing body of clinical evidence suggests that patients with poor bone quality or certain medical conditions that could impair healing can be successfully treated with the Trabecular Metal Dental Implant.”
The following presentations will be given on March 14 in room #146C at the Walter E. Washington Convention Center:
Rehabilitation of Medically Compromised Patients with Dental Implants - Cristian Peron, DDS
Trabecular Metal™ Technology has been used for more than two decades in orthopedic surgery, especially in patients with osteoporosis, cancer, and co-morbidities. Clinical cases will be presented demonstrating the Trabecular Metal Dental Implant for enhanced secondary stability in poor bone quality in medically compromised patients.
Revision Therapy: An Answer to an Increasing Epidemic Known as Peri-implantitis - Suheil M. Boutros, DDS, MS
Knowing patients with a previously failed implant are at a higher risk for additional future failures, how can we improve the odds and provide the best standard of care in these situations? This program will introduce Revision Therapy – implant replacement that intensifies the body’s own healing processes to improve predictability in implant replacement. A decision tree for different treatment modalities will be highlighted, including different restorative treatment options such as CAD/CAM abutments to optimize plaque control and maintain peri-implant health.
Single Unit to Full-Arch Implant Restoration Using a Rapid Recovery Protocol with Two-Week Loading: A Clinical Perspective - Jason Kennedy, DMD
Proper patient selection and case planning can be a winning combination to improve both productivity and patient satisfaction. This lecture will show attendees how to combine an implant protocol with 5-year clinical follow up with digital scanning and patient-specific restorations for a Rapid Recovery solution completed in a matter of weeks, not months, using Trabecular Metal™ Implants in their practices.
Predictable Bone Regeneration and Function with Trabecular Metal™ Implants - Monish Bhola, DDS, MSD
This presentation will highlight advances in bone grafting with a focus on the “dual-zone grafting” concept for better aesthetic outcomes. Immediate function and managing failures requires an implant system that fulfills the three “Rs” (Rapid Recovery, Risk Management, and Revision Therapy) of implant therapy, focusing on Trabecular Metal Implants along with regenerative techniques and materials utilized in supporting these advanced treatments.
“We are excited to showcase the latest clinical evidence related to Trabecular Metal, a disruptive technology platform that has the potential to radically improve the field of implant dentistry for a wide range of patients and clinicians,” continued Indraneel Kanaglekar, Vice President, Global Product Management and R&D. “We are a proud sponsor of the American Academy of Osseointegration Annual Meeting, which complements our deep commitment to excellence in clinical research and professional education.”
Contact Zimmer Biomet for references to all claims.
About Zimmer Biomet
Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer Biomet is a global leader in musculoskeletal healthcare. We design, manufacture and market orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants; and related surgical products.
We collaborate with healthcare professionals around the globe to advance the pace of innovation. Our products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. Together with healthcare professionals, we help millions of people live better lives.
We have operations in more than 25 countries around the world and sell products in more than 100 countries. For more information, visit www.zimmerbiomet.com or follow Zimmer Biomet on Twitter at www.twitter.com/zimmerbiomet.
“We’ll still accommodate on-site registrations during the conference, but lectures are expected to be standing room only and several hands-on workshops are already sold out,” explained ALD executive director Gail Siminovsky, CAE.”
Known internationally as “Dentistry’s Laser Meeting”, ALD 2019 is at the Hilton Dallas/Plano/Granite Park from April 4th – 6th. The meeting’s focus is “The Laser-Systemic Connection: Lighting the Way to a Healthier Mouth and Body.”
We’re very excited about the theme of ALD 2019,” said Siminovsky. “For decades, ALD members were the unsung heroes of oral-systemic health. First by applying laser technology to treat periodontal disease and more recently, by applying light therapy to help patients suffering from the oral mucositis side-effects of chemotherapy, TMJ, sleep apnea and other medical conditions.”
The educational tracks and workshops that support the laser-systemic connection theme include the following:
• Innovation, Wellness and Medically Compromised Patients
• Periodontal Disease Diagnosis and Treatment
• Photobiomodulation
• Obstructive Sleep Apnea
The ALD 2019 program is rounded out by educational sessions and/or workshops on the following topics:
• Hygiene
• Pediatric Dentistry
• Endodontics
• Implantology
• Oral Surgery
• Laser Safety Training
• Financial Planning/Wealth Management
Kicking off ALD 2019 will be keynote speaker Charles Whitney, MD, the nation’s leading physician advocate for bridging the oral-systemic gap. Dr. Whitney’s specialty of heart attack, stroke and dementia prevention relies heavily on collaborating with dental clinicians to accurately diagnose and effectively treat periodontal disease.
Dr. Whitney’s presentation will help ALD 2019 attendees connect the dots on how to bring the message of oral-systemic connections into their practices, “I love watching the lightbulb go on in the eyes of my audience when they learn how to take the oral-systemic message to the streets,” commented Whitney. “I hope I can help ALD members recognize that on a good day they can save a tooth and on a great day they can save a life! “What’s more, Dr. Whitney has seen first-hand the beneficial effects of laser dentistry on his own patients. In fact, he recently referred one of his patients to ALD incoming president Dr. Mel Burchman, who successfully treated the patient’s chemo therapy-induced oral mucositis with photobiomodulation therapy.
“Having Dr. Whitney as our opening keynote speaker will certainly set the tone for ALD 2019,” explains Siminovsky. “Our goal for this meeting is to be the world’s go-to event where the entire dental team can learn how to bridge the oral-systemic gap using laser technology.”
Watch the ALD 2019 preview video by clicking https://bit.ly/2TOAlOL. Register online until March 29th by visiting https://ALD2019.com.
About the Academy of Laser Dentistry:
The Academy of Laser Dentistry (ALD) is the only independent and unbiased non-profit association devoted to laser dentistry and includes clinicians, academicians and researchers in all laser wavelengths. The Academy is devoted to clinical education, research, and the development of standards and guidelines for the safe and effective use of dental laser technology. ALD was founded in 1993, with the merging of the International Academy of Laser Dentistry, the North American Academy of Laser Dentistry and the American Academy of Laser Dentistry. For more information, visit www.LaserDentistry.org.
Endodontic care treats the damage done to the blood vessels, nerves, and tissues in and around the tooth. This damage is often caused by untreated dental caries, which affects a staggering 2.4 billion people worldwide.
The White Paper on Endodontic Care defines the scale of the global burden of endodontic disease and proposes patient-centered solutions to improve endodontic health. The paper was published as part of FDI's Endodontics in General Practice initiative, supported by Dentsply Sirona.
Rather than focusing purely on the roots of the tooth, this paper calls for endodontic care to address a broader set of health outcomes that directly affect the patient, including teeth retention and impact on overall health. Patients are concerned with eliminating pain and keeping the affected tooth healthy and strong over the long term. Considering the patient's perspective in the provision of endodontic care has significant implications for existing treatment guidelines.
"A comprehensive approach to endodontic care puts the patient first," said FDI President Dr Kathryn Kell. "We need to shift away from treatment outcomes that focus solely on technical goals and clinical symptoms after treatment and take a closer look at how we can deliver better care to our patients."
The paper summarizes results of a survey completed by FDI member NDAs to identify obstacles to providing endodontic care. Members reported that limited access to care is an on-going challenge in many countries, and misconceptions of endodontics as a complex or painful procedure frequently deter patients from seeking treatment.
"Untreated endodontic conditions can drastically affect one's quality of life, causing craniofacial pain, difficulty chewing, and trouble sleeping," said Dr Terri Dolan, VP and Chief Clinical Officer at Dentsply Sirona. "We are proud to support FDI's work to actively address these challenges and propose tangible solutions to improve endodontic health worldwide."
Endodontics (in Greek, 'endo' means 'inside' and 'odont' means 'tooth') is the branch of dentistry concerning the conservation and treatment of dental pulp and tissues surrounding the roots of the tooth. FDI's Endodontics in General Practice project guides general dentists on the provision of endodontic care.
About FDI World Dental Federation
FDI is the main representative body for more than 1 million dentists worldwide, with a vision of leading the world to optimal oral health. Its membership comprises some 200 national member associations and specialist groups in over 130 countries.
About Dentsply Sirona
Dentsply Sirona is the world's largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets dental and oral health products as well as consumable medical devices under a portfolio of world class brands.
A team led by the Rutgers Institute for Translational Medicine and Science that includes Princeton University and the New Jersey Institute of Technology has received a National Institutes of Health grant for $29 million over five years for joining the NIH’s Clinical and Translational Science Awards Program (CTSA). The CTSA program at Rutgers University will be known as NJ ACTS: New Jersey Alliance for Clinical and Translational Science. Additional funding from the institutions will grow the program to about $45 million.
Translational science takes observations made in the laboratory, clinic and community and creates interventions that improve the health of individuals and populations – from diagnostics and therapeutics to medical procedures and behavioral interventions. “The ultimate goal is bringing more evidence-based treatments to more patients more quickly,” said Reynold Panettieri, vice chancellor for Translational Medicine and Science and director of Rutgers Institute for Translational Medicine and Science (RITMS). “In addition, our partnership with RWJBarnabas Health gives us a great opportunity to expand our clinical research, connecting the basic science research done by our 200+ investigators to patient care statewide.”
NIH supports a national network of more than 50 CTSAs at medical research institutions nationwide that collaborate to speed the translation of research discoveries into improved patient care. It enables research teams, including scientists, patient advocacy organizations and community members, to tackle system-wide scientific and operational problems in clinical and translational research that no one team can overcome.
The grant will allow Rutgers and its partners to train and cultivate the translational science workforce; engage patients and communities in every phase of the translational process; promote the integration of special and underserved populations in translational research across the human lifespan; innovate processes to increase the quality and efficiency of translational research, particularly of multisite trials; and advance the use of big data information systems. The collaborative program develops innovative approaches to barriers in clinical research, such as the efficient recruitment of research participants and approvals for multisite clinical trials.
Rutgers and its partners will build a new infrastructure for clinical and translational research across the entire state, which will give patients access to clinical trials with cutting edge care. In addition, NJ ACTS will have the capacity to analyze big data to discover trends in population health that can inform basic science research. It will also allow for diversity in clinical trials across Rutgers’ five clinical research units, which include the Adult Clinical Research and Pediatric Clinical Research Unit at Rutgers Robert Wood Johnson Medical School and centers based at Rutgers New Jersey Medical School, Rutgers School of Dental Medicine, and Rutgers Environmental and Occupational Health Sciences Institute.
“This huge grant is a natural outgrowth of the integration of the University of Medicine and Dentistry of New Jersey and Rutgers, and the type of opportunity for New Jersey then envisioned by the state government. It will foster the further development of innovation in New Jersey,” said Brian L. Strom, chancellor of Rutgers Biomedical and Health Sciences and executive vice president for Health Affairs for Rutgers. “It would not have been possible without the combination of resources from these two large great universities as well as the funding provided through our partnership with RWJBarnabas Health. It indicates to the world and to New Jersey industry that New Jersey is now in the big leagues of academic clinical research.”
The grant also will build a pipeline for new clinical investigators by funding two positions a year for five years for junior faculty or professionals finishing their post-doctoral fellowship who can move into faculty positions with two years of guaranteed support. It will fund six positions for graduate students, who will be trained in translational and clinical research.
The grant was awarded due to the strength of RITMS, the alliance between Rutgers Biomedical and Health Sciences, Princeton and NJIT, and the partnerships with community-based organizations, hospitals, community health centers, outpatient practices, data centers and health information exchanges. It reaches nearly seven million of the state’s nine million residents.
Brush your teeth twice per day and floss regularly are habits most people know of, but despite the pleas of dentists nationwide, few follow through on this advice.
Now, dentists are considering a new approach to improve oral health practices among the public: motivational interviewing.
University at Buffalo researchers have received a new $438,000 grant to develop the first online intervention based on motivational interviewing to help dental patients improve oral health behaviors, including frequent brushing and flossing, and slow risk behaviors that negatively affect oral health, such as tobacco and alcohol use.
The two-year grant is funded by the National Institute of Dental and Craniofacial Research in the National Institutes of Health. The investigation is led by Sebastian Ciancio, DDS, SUNY Distinguished Service Professor in the UB School of Dental Medicine; and Kurt Dermen, PhD, senior research scientist in the Jacobs School of Medicine and Biomedical Sciences at UB.
“Books, demonstrations, discussions – none of it is working. Dentists are always trying to motivate people to brush and floss properly, yet half of the U.S. population has some form of gingivitis,” says Ciancio, also director of the UB Center for Dental Studies.
Dermen adds, “Creating an effective online program based on motivational interviewing will make it possible to achieve large-scale improvements in oral health at a relatively low cost.”
Motivational interviewing is a collaborative, goal-oriented counseling style that promotes behavior change by helping patients resolve doubt and indecision. Rather than give direction, the counselor guides patients to identify their own reasons and plans for change.
The researchers turned to this approach due to its effectiveness in treating alcohol and substance abuse. In a previous study, the investigators tested the ability of motivational interviewing to improve brushing and flossing habits in dental patients who suffered from alcohol abuse. The project’s success led to the development of an intervention training manual for dental professionals.
Because dental practices are limited in the amount of time they can spend counseling patients, the new study will modify the training manual into an online intervention that can be easily delivered to patients.
Researchers will conduct focus group interviews with 32 dentists and hygienists and 32 dental patients to guide development of the program. Various iterations of the online intervention will be tested with small sets of patients.
The final version of the intervention will be tested with 24 UB Dental patients, the School of Dental Medicine teaching clinic that provides affordable care to thousands of Western New Yorkers. Patients will report their perceptions of the program’s ability to engage and motivate changes in behavior.
Future research will test the program’s effectiveness and its utility with other populations at risk for oral disease, such as patients diagnosed with HIV or diabetes.
Additional investigators include Christopher Barrick, PhD, senior research scientist in the Jacobs School of Medicine and Biomedical Sciences; and Jennifer Livingston, PhD, associate professor in the UB School of Nursing.
